HomeInsightsResults

Gland Pharma Ltd Quarterly Result

Gland Pharma Ltd Quarterly Result

stocks purchased

₹ 0.9 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

5.0 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Gland Pharma Ltd

NSE: GLAND

Net Profit

₹ 163.53

Last updated on: Nov 25, 2024

Key Highlights

  • The revenue of Gland Pharma Ltd for the Sep '24 is ₹ 1465 crore as compare to the Jun '24 revenue of ₹ 1453 crore. This represent the growth of 0.849882%.
  • The ebitda of Gland Pharma Ltd for the Sep '24 is ₹ 356.72 crore as compare to the Jun '24 ebitda of ₹ 315.82 crore. This represent the growth of 12.950413%.
  • The net profit of Gland Pharma Ltd for the Sep '24 is ₹ 163.53 crore as compare to the Jun '24 net profit of ₹ 143.76 crore. This represent the growth of 13.75209%.

Results Analysis

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 20241776.1
22 Nov 20241756.55
21 Nov 20241788.5
19 Nov 20241778.45
18 Nov 20241772.4
14 Nov 20241771.4
13 Nov 20241705
12 Nov 20241761.95
11 Nov 20241818.15
08 Nov 20241780.95

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Gland Pharma Ltd News Hub

News

Gland Pharma soars as Q2 PAT rises 9% QoQ to Rs 282 cr

On consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore on 2.36% t...

Read more

05 Nov 202410:42

News

Volumes jump at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Hatsun Agro Product Ltd, ABB India Ltd, Bata India Ltd are among the...

Read more

05 Nov 202411:00

News

Volumes soar at Gland Pharma Ltd counter

Chemplast Sanmar Ltd, Mangalore Refinery And Petrochemicals Ltd, K E C International Ltd, ...

Read more

05 Nov 202414:30

News

Gland Pharma to hold board meeting

Gland Pharma will hold a meeting of the Board of Directors of the Company on 4 November 20...

Read more

23 Oct 202410:19

News

Gland Pharma Ltd slips for fifth straight session

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 18...

Read more

19 Sep 202413:35

News

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 193...

Read more

09 Sep 202413:05

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

Sep 2021

PPT

July 2021

TranscriptPPT

Feb 2021

Transcript

FAQ's For Gland Pharma Ltd Quarterly Result

What is the EPS of Gland Pharma Ltd stock?

The Earnings Per Share (EPS) of Gland Pharma Ltd is 41.98. An EPS is the amount of net income attributed to each share of a common stock.

How is Gland Pharma Ltd EPS calculated?

The EPS of Gland Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Gland Pharma Ltd report its EPS?

Gland Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Gland Pharma Ltd EPS?

Factors that influence the EPS of Gland Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Gland Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Gland Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*